Please assess the completion status of the following clinical trial:

Trial Title: Pilot Evaluation of Platelet Rich Fibrin Matrix (PRFM) for the Correction of Nasolabial Folds

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1/PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* healthy adults~* aged 25- 75 years~* with moderate to severe nasolabial folds~Exclusion Criteria:~* pregnant~* allergy to local anesthetics~* history of bleeding disorder~* active infection at the treatment site~* injectable filler in the nasolabial folds within past year

- Gender: FEMALE
- Minimum Age: 25 Years
- Maximum Age: 75 Years
- Healthy Volunteers: t

Study Arms:
- platelet rich fibrin matrix (Type: ACTIVE_COMPARATOR): Both nasolabial folds treated with 0-2 cc of autologous platelet rich fibrin matrix,sufficient to efface nasolabial fold

Based on this trial design, predict the completion outcome and termination type (if applicable).